Full Breakdown
Breakthrough in Phage Research: New RNA Molecule Offers Hope Against Superbugs
12/19/2025, 9:29:35 PM
Discovery of PreS RNA Molecule
Researchers from the Hebrew University of Jerusalem have identified a novel RNA molecule named PreS, which has the potential to enhance treatments for antibiotic-resistant bacteria, commonly referred to as "superbugs." This discovery involves the interaction between PreS and bacteriophages—viruses that infect and destroy bacteria. The study, led by PhD student Aviezer Silverman and MSc student Raneem Nashef, alongside computational biologist Reut Wasserman, was published in the journal *Molecular Cell*. Dr. Sahar Melamed, head of the Melamed lab, emphasized the urgency of addressing antibiotic resistance, which the World Health Organization identified as a significant global health threat, leading to approximately 1.27 million deaths worldwide in 2019.
Historical Context of Phage Research
Bacteriophages were first discovered in 1917 by French-Canadian microbiologist Félix d’Hérelle, who noted their ability to target and destroy specific bacteria. However, interest in phage research waned after the advent of antibiotics. As antibiotic resistance has escalated, researchers have revisited phage therapy as a viable solution. In Israel, the establishment of the Israel Phage Therapy Center in 2018, in collaboration with Hadassah Medical Center, has focused on harnessing phages to combat bacterial infections, particularly in light of rising cases among IDF soldiers during the Gaza conflict.
Mechanism of Action
The PreS molecule enables bacteriophages to hijack the replication machinery of bacterial cells, allowing them to reproduce efficiently and ultimately burst out of the infected cell, leading to bacterial death. This mechanism was elucidated using a technique called RIL-seq (RNA Interaction by Ligation and sequencing), which maps RNA interactions within cells during phage infection. Melamed noted that the discovery of PreS within the lambda phage, which targets E. coli, was unexpected, as it had not been previously identified despite extensive study of the virus over the past 75 years.
Implications for Phage Therapy
The findings regarding PreS provide critical insights into the molecular interactions between phages and bacteria, potentially paving the way for more effective phage therapies. Melamed stated that understanding how phages manipulate bacterial systems could lead to tailored treatments that specifically target resistant bacteria. The lab's future research will focus on identifying additional RNA molecules in various phages to further explore their roles in bacterial manipulation.
Criticism & Opposition
While the research presents promising avenues for combating antibiotic resistance, some experts caution that phage therapy is still in its infancy and may not be a panacea. Concerns regarding the specificity of phages, potential side effects, and the need for regulatory frameworks to ensure safety and efficacy remain prevalent in discussions about the future of phage therapy.
Verbatim Quotes
“Antibiotic resistance is one of the most serious global health threats of our time,” — Dr. Sahar Melamed, Hebrew University of Jerusalem
“PreS hijacks the bacterium’s replication machinery,” — Dr. Sahar Melamed, Hebrew University of Jerusalem
“Scientists are actively seeking alternative treatments for antimicrobial resistance,” — Dr. Sahar Melamed, Hebrew University of Jerusalem
The ongoing research into the PreS RNA molecule and its implications for phage therapy represents a significant step forward in the fight against antibiotic-resistant infections, highlighting the need for continued exploration in this critical area of public health.
